[PDF] Top 20 Cirugía del pie neurológico: nuestra experiencia y resultados

... Second, for drugs approved between 1993—2017, we identify whether the drug received a priority review or a standard review. The priority review designation pro- gram began in 1992, and allows for an expedited FDA review ... See full document

... The paper is organised in five sections. The first provides a brief outline of policy development in this area and indicates that since 1997, collaborative and partnership approaches have been promoted as a key way of ... See full document

... to investigating the quality of urban environment according to the 5 urban landscape indicators; Land use, Green space, Population and Floor density, Accessibility and physical quality in Noor Town of ... See full document

... As part of its programme on the "Disappearance of countryside and semi-natural recreational areas", Switzerland has been investigating changes in non­ linear landscape components and lin[r] ... See full document

... the product strategy highlights the importance of taking a product/service focus in social marketing aimed at establishing a product-market-fit that provides a market solution, such as providing ... See full document

... of product, listed in table ...a product was made to one agency but did not appear in the results for the other agency, a search with no date restriction on was performed to identify any applications made ... See full document

... medicinal product can obtain an OMP designation for multiple conditions and an OMP designation can be granted to multiple medicinal products targeting the same oncological ...for Orphan Medicinal Products ... See full document

... fully developed legs inside the larval thorax rather than growing out distally. A similar appendage phenotype was observed in an insertional mutant identified in the GEKU screen [55] which is located in the RhoGEF2 gene. ... See full document

... Foster et al., 1997a; Gilbom et a l, 2001; Lee et a l, 2002;). Furthermore, there is considerable literature on caregiving, but this is restricted primarily to the developed world. Recent studies have focussed on ... See full document

... While the early benefit assessment and appraisal of clinical evidence itself is a very clear and trans- parent procedure, no official algorithm exists for a prediction of levels of negotiated price discounts [4, 14]. ... See full document

... to orphan drugs, there is a paucity of available treatments for rare ...of orphan drugs [3, 4, 8] and to address licens- ing regulations and pricing and reimbursement of these drugs [4, 8–10]; such economic ... See full document

... Emerging theories of knowledge construction do not focus exclusively on formal education but account for a new ecology of learning experiences based on the ubiquity of the learning experiences enabled by ICT. There is ... See full document

... an orphan drug development pathway can vary within same disease entity: both tocilizumab and canakinumab are approved for the treat- ment of systemic juvenile idiopathic ...the orphan program with ... See full document

... allowed us to perform an unbiased molecular characterisation, revealing that 7 of the 10 predicted miR-196 Hox targets are statistically upregulated following loss of miR-196 function at a time-point relevant to ... See full document

... Patient recruitment and retention are the biggest chal- lenges in clinical trials. The Clinical Trial Act legislation was implemented in the US to regulate patient compen- sation during clinical trials. Patients ... See full document

... inner product can be thought of as a projection of one vector onto another ...“dot product” of two ordinary (Euclidean) vectors is an example of an inner ...inner product between the two functions x ... See full document

... Another solution for improving soil physical and hydraulic properties is by increasing the organic carbon pool through the addition of biochar or charcoal (Abel et al., 2013; Asai et al., 2009; Bayabil et al., 2015; ... See full document

... Where a marketing authorisation is granted pursuant to Regulation EEC 2309/93 in respect of an orphan medicinal product, the Community and the Member States shall not, for a period of te[r] ... See full document

... of Orphan Status at the time of Marketing Authorisation, the sponsors should check current re- ported prevalences as they can change over time due to a multitude of factors such as the introduction of new ... See full document

... for orphan product des- ignation, overseeing the seven year exclusive marketing for orphan products, coordinating research study design assistance for sponsors of orphan drugs, encouraging ... See full document